These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9810957)

  • 21. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM; Riis A; Nørgaard JP; Djurhuus JC
    BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years.
    Kuo HC
    Urology; 2002 Apr; 59(4):485-9. PubMed ID: 11927295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
    Rembratt A; Riis A; Norgaard JP
    Neurourol Urodyn; 2006; 25(2):105-9. PubMed ID: 16304673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP; Zinner NR; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
    Kamperis K; Hagstroem S; Faerch M; Mahler B; Rittig S; Djurhuus JC
    Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis.
    Kinn AC; Larsson PO
    Scand J Urol Nephrol; 1990; 24(2):109-12. PubMed ID: 2192444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
    Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
    Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies confirm: nightly micturition frequency lowered].
    MMW Fortschr Med; 2004 Sep; 146(40):53. PubMed ID: 15529677
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term home studies of water balance in patients with nocturnal enuresis.
    Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.
    Rittig S; Jensen AR; Jensen KT; Pedersen EB
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP; Herschorn S; Albei CD; van der Meulen EA
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study.
    Kadir RA; Lee CA; Sabin CA; Pollard D; Economides DL
    Haemophilia; 2002 Nov; 8(6):787-93. PubMed ID: 12410648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cure for late-night toilet trips?
    Health News; 2004 Jan; 10(1):5. PubMed ID: 15002376
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled trial of desmopressin and behavioral therapy for nocturnal enuresis.
    Kahan E; Morel D; Amir J; Zelcer C
    Medicine (Baltimore); 1998 Nov; 77(6):384-8. PubMed ID: 9854601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of response to desmopressin in children and adolescents with monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Skoog S; Zaontz MR; Sihelnik S
    Scand J Urol Nephrol Suppl; 1995; 173():109-10; discussion 110-1. PubMed ID: 8719580
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years.
    Rembratt A; Graugaard-Jensen C; Senderovitz T; Norgaard JP; Djurhuus JC
    Eur J Clin Pharmacol; 2004 Aug; 60(6):397-402. PubMed ID: 15197520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.